Drug metabolism and personalized therapy

Keyphrases

Publications

2024

Mo'tasem M Alsmadi
Bottom-up PBPK modeling of phenytoin brain disposition in postpartum newborns after intrauterine dosing. Drug metabolism and personalized therapy (2024)
Ankit Kumar Dubey, Ishnoor Kaur, Reecha Madaan, Shikha Raheja, Rajni Bala, Manoj Garg, Suresh Kumar, Viney Lather, Vineet Mittal, Deepti Pandita, Rohit Gundamaraju, Rajeev K Singla, Rohit Sharma
Unlocking the potential of oncology biomarkers: advancements in clinical theranostics. Drug metabolism and personalized therapy (2024)
Asia Khanum, Javed Ali Khan, Arisha Shahid, Mohd Riyazuddin, Mansoor Ahmad Siddiqui
Effect of a polyherbal Unani formulation on left ventricular diastolic dysfunction in hypertensive patients - a randomized single blind placebo controlled clinical trial. Drug metabolism and personalized therapy (2024)
Stefan Németh, Gernot Kriegshäuser, Hasmik Hayrapetyan, Christian Oberkanins, Tamara Sarkisian
Allelic frequencies of polymorphism c.521T>C (rs4149056) favor preemptive SLCO1B1 genotyping in Armenia. Drug metabolism and personalized therapy (2024)
Natalia P Denisenko, Anna S Zhiryakova, Ivan V Sychev, Alexander V Kryukov, Svetlana N Tuchkova, Olga Y Vakulenko, Oleg V Averkov, Valery I Vechorko, Karin Badavievich Mirzaev, Dmitry Alekseevich Sychev
Clinical and pharmacogenetic features of patients with upper gastrointestinal lesions at a multidisciplinary hospital: the role of nonsteroidal anti-inflammatory drugs. Drug metabolism and personalized therapy (2024)
Aaron G Whitt, Saeed A Jortani
CYP2D6 inhibition by diphenhydramine leading to fatal hydrocodone overdose. Drug metabolism and personalized therapy (2024)
Kairat Rysbekov, Sagira Abrakhmanova, Rashida Satybaeva, Yekaterina Starosvetova, Almagul Kushugulova
Helicobacter pylori eradication therapy for children. Drug metabolism and personalized therapy (2024)
Mohammad Abu Zahra, Abdulla Al-Taher, Mohamed Alquhaidan, Tarique Hussain, Izzeldin Ismail, Indah Raya, Mahmoud Kandeel
The synergy of artificial intelligence and personalized medicine for the enhanced diagnosis, treatment, and prevention of disease. Drug metabolism and personalized therapy (2024)
Saja Majeed Shareef, Raghad Abdulsalam Khaleel, Taif M Maryoosh
Nephroprotective effect of cranberry ( Vaccinium oxycoccos ) in streptozocin-induced diabetic nephropathy in mice. Drug metabolism and personalized therapy (2024)
Elango Dhivya, Ramasamy Kesavan, Nair P Pradeep
Impact of ABCB1 genetic polymorphism on carbamazepine dose requirement among Southern Indian persons with epilepsy. Drug metabolism and personalized therapy (2024)
Aparna Shil, Arnab Banerjee, Jayati Roy, Manisha Pal, Debasmita Das, Rajarshi Paul, Bithin Kumar Maji, Mausumi Sikdar Nee Bhakta
The potential antibacterial effects of tea polyphenols. Drug metabolism and personalized therapy (2024)
Alena I Skripka, Pavel M Krupenin, Olga N Kozhanova, Anna A Kudryavtseva, Ludmila V Fedina, Kristina A Akmalova, Pavel O Bochkov, Anastasiya A Sokolova, Dmitriy A Napalkov, Dmitriy A Sychev
The impact of ABCB1 , CYP3A4 and CYP3A5 gene polymorphisms on apixaban trough concentration and bleeding risk in patients with atrial fibrillation. Drug metabolism and personalized therapy (2024)
Lana Nasrallah Mousa, Yazun Jarrar, Munir Gharaibeh, Hussam Alhawari
Effects of tumor necrosis factor- α rs1800629 and interleukin- 10 rs1800872 genetic variants on type 2 diabetes mellitus susceptibility and metabolic parameters among Jordanians. Drug metabolism and personalized therapy (2024)
Prasanth S Ariyannur, Veena P Menon, Keechilat Pavithran, Roopa R Paulose, Reenu A Joy, Damodaran M Vasudevan
Molecular pathogenesis of microsatellite instability-high early state colorectal adenocarcinoma in India. Drug metabolism and personalized therapy (2024)

volume 39, number 1, 2024

Ankit Kumar Dubey, Ishnoor Kaur, Reecha Madaan, Shikha Raheja, Rajni Bala, Manoj Garg, Suresh Kumar, Viney Lather, Vineet Mittal, Deepti Pandita, Rohit Gundamaraju, Rajeev K Singla, Rohit Sharma
Unlocking the potential of oncology biomarkers: advancements in clinical theranostics. Drug metabolism and personalized therapy 39 (1) (2024)
Saja Majeed Shareef, Raghad Abdulsalam Khaleel, Taif M Maryoosh
Nephroprotective effect of cranberry ( Vaccinium oxycoccos ) in streptozocin-induced diabetic nephropathy in mice. Drug metabolism and personalized therapy 39 (1) (2024)
Ankit Kumar Dubey, Ishnoor Kaur, Reecha Madaan, Shikha Raheja, Rajni Bala, Manoj Garg, Suresh Kumar, Viney Lather, Vineet Mittal, Deepti Pandita, Rohit Gundamaraju, Rajeev K Singla, Rohit Sharma
Unlocking the potential of oncology biomarkers: advancements in clinical theranostics. Drug metabolism and personalized therapy 39 (1) (2024)
Saja Majeed Shareef, Raghad Abdulsalam Khaleel, Taif M Maryoosh
Nephroprotective effect of cranberry ( Vaccinium oxycoccos ) in streptozocin-induced diabetic nephropathy in mice. Drug metabolism and personalized therapy 39 (1) (2024)
Elango Dhivya, Ramasamy Kesavan, Nair P Pradeep
Impact of ABCB1 genetic polymorphism on carbamazepine dose requirement among Southern Indian persons with epilepsy. Drug metabolism and personalized therapy 39 (1) (2024)
Ankit Kumar Dubey, Ishnoor Kaur, Reecha Madaan, Shikha Raheja, Rajni Bala, Manoj Garg, Suresh Kumar, Viney Lather, Vineet Mittal, Deepti Pandita, Rohit Gundamaraju, Rajeev K Singla, Rohit Sharma
Unlocking the potential of oncology biomarkers: advancements in clinical theranostics. Drug metabolism and personalized therapy 39 (1) (2024)
Elango Dhivya, Ramasamy Kesavan, Nair P Pradeep
Impact of ABCB1 genetic polymorphism on carbamazepine dose requirement among Southern Indian persons with epilepsy. Drug metabolism and personalized therapy 39 (1) (2024)
Elango Dhivya, Ramasamy Kesavan, Nair P Pradeep
Impact of ABCB1 genetic polymorphism on carbamazepine dose requirement among Southern Indian persons with epilepsy. Drug metabolism and personalized therapy 39 (1) (2024)
Saja Majeed Shareef, Raghad Abdulsalam Khaleel, Taif M Maryoosh
Nephroprotective effect of cranberry ( Vaccinium oxycoccos ) in streptozocin-induced diabetic nephropathy in mice. Drug metabolism and personalized therapy 39 (1) (2024)
Elango Dhivya, Ramasamy Kesavan, Nair P Pradeep
Impact of ABCB1 genetic polymorphism on carbamazepine dose requirement among Southern Indian persons with epilepsy. Drug metabolism and personalized therapy 39 (1) (2024)

volume 39, number 2, 2024

Mohammad Abu Zahra, Abdulla Al-Taher, Mohamed Alquhaidan, Tarique Hussain, Izzeldin Ismail, Indah Raya, Mahmoud Kandeel
The synergy of artificial intelligence and personalized medicine for the enhanced diagnosis, treatment, and prevention of disease. Drug metabolism and personalized therapy 39 (2) (2024)
Lana Nasrallah Mousa, Yazun Jarrar, Munir Gharaibeh, Hussam Alhawari
Effects of tumor necrosis factor- α rs1800629 and interleukin- 10 rs1800872 genetic variants on type 2 diabetes mellitus susceptibility and metabolic parameters among Jordanians. Drug metabolism and personalized therapy 39 (2) (2024)
Natalia P Denisenko, Anna S Zhiryakova, Ivan V Sychev, Alexander V Kryukov, Svetlana N Tuchkova, Olga Y Vakulenko, Oleg V Averkov, Valery I Vechorko, Karin Badavievich Mirzaev, Dmitry Alekseevich Sychev
Clinical and pharmacogenetic features of patients with upper gastrointestinal lesions at a multidisciplinary hospital: the role of nonsteroidal anti-inflammatory drugs. Drug metabolism and personalized therapy 39 (2) (2024)
Aaron G Whitt, Saeed A Jortani
CYP2D6 inhibition by diphenhydramine leading to fatal hydrocodone overdose. Drug metabolism and personalized therapy 39 (2) (2024)
Alena I Skripka, Pavel M Krupenin, Olga N Kozhanova, Anna A Kudryavtseva, Ludmila V Fedina, Kristina A Akmalova, Pavel O Bochkov, Anastasiya A Sokolova, Dmitriy A Napalkov, Dmitriy A Sychev
The impact of ABCB1 , CYP3A4 and CYP3A5 gene polymorphisms on apixaban trough concentration and bleeding risk in patients with atrial fibrillation. Drug metabolism and personalized therapy 39 (2) (2024)
Lana Nasrallah Mousa, Yazun Jarrar, Munir Gharaibeh, Hussam Alhawari
Effects of tumor necrosis factor- α rs1800629 and interleukin- 10 rs1800872 genetic variants on type 2 diabetes mellitus susceptibility and metabolic parameters among Jordanians. Drug metabolism and personalized therapy 39 (2) (2024)
Aaron G Whitt, Saeed A Jortani
CYP2D6 inhibition by diphenhydramine leading to fatal hydrocodone overdose. Drug metabolism and personalized therapy 39 (2) (2024)
Kairat Rysbekov, Sagira Abrakhmanova, Rashida Satybaeva, Yekaterina Starosvetova, Almagul Kushugulova
Helicobacter pylori eradication therapy for children. Drug metabolism and personalized therapy 39 (2) (2024)

2023

Ryan Varghese, Gargi Digholkar, Jainam Karsiya, Sahil Salvi, Jeenam Shah, Dileep Kumar, Rohit Sharma
PDE5 inhibitors: breaking new grounds in the treatment of COVID-19. Drug metabolism and personalized therapy (2023)

volume 39, number 1, 2023

Devanathan Reka, Priyadharsini Rajendran, Sivaranjini Ramasamy, Senthamizh Selvan, Kesavan Ramasamy
Association of ITPA 94C>A genetic polymorphisms with azathioprine induced adverse effects in the South Indian population. Drug metabolism and personalized therapy 39 (1) (2023)
Devanathan Reka, Priyadharsini Rajendran, Sivaranjini Ramasamy, Senthamizh Selvan, Kesavan Ramasamy
Association of ITPA 94C>A genetic polymorphisms with azathioprine induced adverse effects in the South Indian population. Drug metabolism and personalized therapy 39 (1) (2023)
Devanathan Reka, Priyadharsini Rajendran, Sivaranjini Ramasamy, Senthamizh Selvan, Kesavan Ramasamy
Association of ITPA 94C>A genetic polymorphisms with azathioprine induced adverse effects in the South Indian population. Drug metabolism and personalized therapy 39 (1) (2023)
Devanathan Reka, Priyadharsini Rajendran, Sivaranjini Ramasamy, Senthamizh Selvan, Kesavan Ramasamy
Association of ITPA 94C>A genetic polymorphisms with azathioprine induced adverse effects in the South Indian population. Drug metabolism and personalized therapy 39 (1) (2023)

volume 38, number 1, 2023

Ingrid Fricke-Galindo, Adrián LLerena
News in DMPT: Leaders in Pharmacogenetics Section. Drug metabolism and personalized therapy 38 (1) (2023)
Ingrid Fricke-Galindo, Adrián LLerena
News in DMPT: Leaders in Pharmacogenetics Section. Drug metabolism and personalized therapy 38 (1) (2023)
Ingrid Fricke-Galindo, Adrián LLerena
News in DMPT: Leaders in Pharmacogenetics Section. Drug metabolism and personalized therapy 38 (1) (2023)
Ingrid Fricke-Galindo, Adrián LLerena
News in DMPT: Leaders in Pharmacogenetics Section. Drug metabolism and personalized therapy 38 (1) (2023)

volume 38, number 3, 2023

Natalia P Denisenko, Anastasiya A Kachanova, Ivan V Sychev, Gregory N Shuev, Oksana M Perfilieva, Reis H Mukhamadiev, Ruslan E Kazakov, Olga I Milyutina, Olga V Konenkova, Sergey A Ryzhkin, Elena M Zhmaeva, Sergey L Kirienko, Dmitriy V Ivashchenko, Irina Vladimirovna Bure, Alexander S Ametov, Irina Vladimirovna Poddubnaya, Karin Badavievich Mirzaev, Dmitry Alekseevich Sychev
Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients. Drug metabolism and personalized therapy 38 (3) (2023)
Ingrid Fricke-Galindo, Adrián LLerena
Relevance of personalized medicine for improving traditional medicine. Drug metabolism and personalized therapy 38 (3) (2023)
Kirti Raina, Ruchika Kumari, Palak Thakur, Rohit Sharma, Randeep Singh, Abhinay Thakur, Vikas Anand, Rohit Sharma, Ashun Chaudhary
Mechanistic role and potential of Ayurvedic herbs as anti-aging therapies. Drug metabolism and personalized therapy 38 (3) (2023)

volume 38, number 4, 2023

Ryan Varghese, Gargi Digholkar, Jainam Karsiya, Sahil Salvi, Jeenam Shah, Dileep Kumar, Rohit Sharma
PDE5 inhibitors: breaking new grounds in the treatment of COVID-19. Drug metabolism and personalized therapy 38 (4) (2023)
Ingrid Fricke-Galindo, Adrián LLerena
Ancestromics. Drug metabolism and personalized therapy 38 (4) (2023)
Ryan Varghese, Gargi Digholkar, Jainam Karsiya, Sahil Salvi, Jeenam Shah, Dileep Kumar, Rohit Sharma
PDE5 inhibitors: breaking new grounds in the treatment of COVID-19. Drug metabolism and personalized therapy 38 (4) (2023)
Oksana Dmitryevna Gurieva, Marina Ivanovna Savelyeva, Timur Tejmurazovich Valiev, Zhannet Alimovna Sozaeva, Svetlana Nikolaevna Kondratenko, Mikhail Vitalyevich Ilyin
Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia. Drug metabolism and personalized therapy 38 (4) (2023)
Ingrid Fricke-Galindo, Adrián LLerena
Ancestromics. Drug metabolism and personalized therapy 38 (4) (2023)
Oksana Dmitryevna Gurieva, Marina Ivanovna Savelyeva, Timur Tejmurazovich Valiev, Zhannet Alimovna Sozaeva, Svetlana Nikolaevna Kondratenko, Mikhail Vitalyevich Ilyin
Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia. Drug metabolism and personalized therapy 38 (4) (2023)